All Stories

  1. Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study
  2. The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis
  3. Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer